Cited by 383Reproductive tract infections researchUrinary Tract Infections ManagementGynecological conditions and treatments

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Open access

Cohen, Craig R., Wierzbicki, Michael R., French, Audrey L., Morris, Sheldon, Newmann, Sara, Reno, Hilary, Green, Lauri, Miller, Steve, Powell, Jonathan, Parks, Thomas, Hemmerling, Anke·2020·New England Journal of Medicine

DOI 10.1056/nejmoa1915254PMC PMC7362958

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Bacterial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatment with an antibiotic agent. The high incidence of recurrence suggests the need for new treatments to prevent recurrent bacterial vaginosis. METHODS: CTV-05 (Lactin-V) to prevent the recurrence of bacterial vaginosis. Women 18 to 45 years of age who had received a diagnosis of bacterial vaginosis and who had completed a course of vaginal metronidazole gel as part of the eligibility requirements were randomly assigned, in a 2:1 ratio, to receive vaginally administered Lactin-V or placebo for 11 weeks; follow-up occurred through week 24. The primary outcome was the percentage of women who had a recurrence of bacterial vaginosis by week 12. RESULTS: CTV-05 was detected in 79% of participants in the Lactin-V group. The percentage of participants who had at least one adverse event related to Lactin-V or placebo by week 24 did not differ significantly between the groups. The percentage of participants with local or systemic adverse events was similar in the two groups. CONCLUSIONS: The use of Lactin-V after treatment with vaginal metronidazole resulted in a significantly lower incidence of recurrence of bacterial vaginosis than placebo at 12 weeks. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT02766023.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1915254

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Inference and missing data
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,332
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Nonspecific vaginitis
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D. A., & Holmes, K. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91112-9 · Cited by 2,412
A Case–Control Study of Chorioamnionic Infection and Histologic Chorioamnionitis in Prematurity
Hillier, S. L., Martius, J., Krohn, M. A., Kiviat, N. B., Holmes, K. K., & Eschenbach, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191503 · Cited by 988
Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease Acquisition
Martin, H., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B. H., Mandaliya, K. N., Ndinya‐Achola, J. O., Bwayo, J., & Kreiss, J. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/315127 · Cited by 884
Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract
Anahtar, M. N., Byrne, E. H., Doherty, K. E., Bowman, B. A., Yamamoto, H. S., Soumillon, M., Padavattan, N., Ismail, N., Moodley, A., Sabatini, M. E., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.019 · Cited by 814
High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence
Bradshaw, C. S., Morton, A. N., Hocking, J. S., Garland, S. M., Morris, M. B., Moss, L. M., Horvath, L. B., Kuzevska, I., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503780 · Cited by 793
Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women
Gosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696
Bacterial vaginosis and disturbances of vaginal flora
Taha, T. E., Hoover, D. R., Dallabetta, G., Kumwenda, J., Mtimavalye, L. A. R., Yang, L.-P., Liomba, G. N., Broadhead, R., Chiphangwi, J. D., & Miotti, P. (1998) · AIDS · doi:10.1097/00002030-199813000-00019 · Cited by 633
Diagnosis and clinical manifestations of bacterial vaginosis
Eschenbach, D. A., Hillier, S. L., Critchlow, C. W., Stevens, C. E., DeRouen, T. A., & Holmes, K. K. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90078-6 · Cited by 548
High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis
Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S., & Barnabas, R. V. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000972 · Cited by 531
Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract Infection
Stapleton, A. E., Au-Yeung, M., Hooton, T. M., Fredricks, D. N., Roberts, P. L., Czaja, C. A., Yarova-Yarovaya, Y., Fiedler, T., Cox, M., & Stamm, W. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir183 · Cited by 484
Prevalence of Bacterial Vaginosis
Allsworth, J. E., & Peipert, J. F. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000247627.84791.91 · Cited by 450
Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples
Cohen, C. R., Lingappa, J. R., Baeten, J. M., Ngayo, M. O., Spiegel, C. A., Hong, T., Donnell, D. J., Celum, C., Kapiga, S., Delany‐Moretlwe, S., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001251 · Cited by 389
Self-citation
Bacterial vaginosis as a risk factor for post-cesarean endometritis.
Watts, D. H., Krohn, M. A., Hillier, S. L., & Eschenbach, D. A. (1990) · PubMed · Cited by 274
Validity of the Vaginal Gram Stain for the Diagnosis of Bacterial Vaginosis
Schwebke, J. R. (1996) · Obstetrics and Gynecology · doi:10.1016/0029-7844(96)00233-5 · Cited by 266
Bacterial Vaginosis and Susceptibility to HIV Infection in South African Women: A Nested Case‐Control Study
Myer, L., Denny, L., Telerant, R., Souza, M. D., Wright, T. C., & Kuhn, L. (2005) · The Journal of Infectious Diseases · doi:10.1086/462427 · Cited by 265
The Burden of Bacterial Vaginosis: Women’s Experience of the Physical, Emotional, Sexual and Social Impact of Living with Recurrent Bacterial Vaginosis
Bilardi, J., Walker, S. M., Temple-Smith, M. J., McNair, R., Mooney‐Somers, J., Bellhouse, C., Fairley, C. K., Chen, M. Y., & Bradshaw, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074378 · Cited by 225
Role of bacterial vaginosis–associated microorganisms in endometritis
Hillier, S. L., Kiviat, N. B., Hawes, S. E., Hasselquist, M. B., Wölner‐Hanssen, P., Eschenbach, D. A., & Holmes, K. K. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70158-8 · Cited by 209
Probiotics for the treatment of bacterial vaginosis
Senok, A. C., Verstraelen, H., Temmerman, M., & Botta, G. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006289.pub2 · Cited by 196
Recurrence of Bacterial Vaginosis Is Significantly Associated With Posttreatment Sexual Activities and Hormonal Contraceptive Use
Bradshaw, C. S., Vodstrcil, L. A., Hocking, J. S., Law, M. G., Pirotta, M. V., Garland, S. M., de Guingand, D. L., Morton, A. N., & Fairley, C. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis1030 · Cited by 163
Lactobacilli‐containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs
van de Wijgert, J., & Verwijs, M. (2020) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15870 · Cited by 162
A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity
Hillier, S., Martius, J., Krohn, M. A., Kiviat, N. B., Holmes, K. K., & Eschenbach, D. A. (1989) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(89)90145-8 · Cited by 131
Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.
Marrazzo, J. M., Fiedler, T. L., Srinivasan, S., Thomas, K. K., Liu, C., Ko, D., Xie, H., Saracino, M., & Fredricks, D. N. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis242 · Cited by 123
Phase 2a Study Assessing Colonization Efficiency, Safety, and Acceptability of Lactobacillus crispatus CTV-05 in Women With Bacterial Vaginosis
Hemmerling, A., Harrison, W., Schroeder, A., Park, J., Korn, A. P., Shiboski, S. C., Foster-Rosales, A. F., & Cohen, C. R. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181e50026 · Cited by 112
Self-citation
Vaginal Colonization by ProbioticLactobacillus crispatusCTV‐05 Is Decreased by Sexual Activity and Endogenous Lactobacilli
Beamer, M. A., Meyn, L. A., Murray, P. J., Busse, B., & Hillier, S. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/598686 · Cited by 108
Phase I Trial of aLactobacillus crispatusVaginal Suppository for Prevention of Recurrent Urinary Tract Infection in Women
Czaja, C. A., Stapleton, A. E., Yarova‐Yarovaya, Y., & Stamm, W. E. (2007) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2007/35387 · Cited by 98
DNA Fingerprinting of Lactobacillus crispatus Strain CTV-05 by Repetitive Element Sequence-Based PCR Analysis in a Pilot Study of Vaginal Colonization
Beamer, M. A., & Hillier, S. L. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.5.1881-1887.2003 · Cited by 84
The influence of the vaginal microbiota on preterm birth: A systematic review and recommendations for a minimum dataset for future research
Peelen, M. J. C. S., Luef, B. M., Lamont, R., de Milliano, I., Jensen, J. S., Limpens, J., Hajenius, P. J., Jørgensen, J. S., & Menon, R. (2019) · Placenta · doi:10.1016/j.placenta.2019.03.011 · Cited by 84
The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women
Karim, S. S. A., Baxter, C., Passmore, J.-A. S., McKinnon, L. R., & Williams, B. L. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25300 · Cited by 74
Vaginal microbiota transplantation for the treatment of bacterial vaginosis: a conceptual analysis
Ma, D., Chen, Y., & Chen, T. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz025 · Cited by 72
Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa
Cohen, C. R., Moscicki, A., Scott, M. E., Ma, Y., Shiboski, S. C., Bukusi, E. A., Daud, I. I., Rebbapragada, A., Brown, J., & Kaul, R. (2010) · AIDS · doi:10.1097/qad.0b013e32833c323b · Cited by 70
Self-citation
Effects of Bacterial Vaginosis-Associated Bacteria and Sexual Intercourse on Vaginal Colonization With the Probiotic Lactobacillus crispatus CTV-05
Ngugi, B. M., Hemmerling, A., Bukusi, E. A., Kikuvi, G. M., Gikunju, J. K., Shiboski, S. C., Fredricks, D. N., & Cohen, C. R. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182267ac4 · Cited by 69
Self-citation
Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing
van de Wijgert, J. H. H. M., Verwijs, M. C., Agaba, S. K., Bronowski, C., Mwambarangwe, L., Uwineza, M., Lievens, E., Nivoliez, A., Ravel, J., & Darby, A. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-60671-6 · Cited by 68
Bacterial vaginosis and postoperative infections
Soper, D. E. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90343-h · Cited by 63
Diversity of Cervicovaginal Microbiota Associated with Female Lower Genital Tract Infections
Ling, Z., Liu, X., Chen, X., Zhu, H., Nelson, K. E., Xia, Y., Li, L., & Xiang, C. (2011) · Microbial Ecology · doi:10.1007/s00248-011-9813-z · Cited by 59
Tinidazole vs metronidazole for the treatment of bacterial vaginosis
Schwebke, J. R., & Desmond, R. A. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.10.898 · Cited by 59
Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women
McClelland, R. S., Balkus, J. E., Lee, J. Y., Anzala, O. A., Kimani, J., Schwebke, J. R., Bragg, V., Lensing, S., & Kavak, L. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu818 · Cited by 51
Phase 1 Dose-Ranging Safety Trial of Lactobacillus crispatus CTV-05 for the Prevention of Bacterial Vaginosis
Hemmerling, A., Harrison, W., Schroeder, A., Park, J., Korn, A. P., SHIBOSKI, S. C., & Cohen, C. R. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181a74924 · Cited by 48
Self-citation
Proteome profiles of vaginal fluids from women affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment
Cruciani, F., Wasinger, V. C., Turroni, S., Calanni, F., Donders, G. G. G., Brigidi, P., & Vitali, B. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt244 · Cited by 22
BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial
Mullins, M. Z., & Trouton, K. (2015) · Trials · doi:10.1186/s13063-015-0852-5 · Cited by 20
The Posttrial Effect of Oral Periodic Presumptive Treatment for Vaginal Infections on the Incidence of Bacterial Vaginosis and Lactobacillus Colonization
Balkus, J. E., Jaoko, W. G., Mandaliya, K. N., Richardson, B. A., Masese, L. N., Gitau, R., Kiarie, J. N., Marrazzo, J. M., Farquhar, C., & McClelland, R. S. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31824790d7 · Cited by 19
Trypan Blue Staining to Determine Vaginal Exposure in Two Types of Plastic Vaginal Applicators Containing Two Different Microbicide Formulations
Hemmerling, A., Harrison, W. G., Brown, J., Moscicki, B., Oziemkowska, M., Bukusi, E. A., & Cohen, C. R. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182641f08 · Cited by 11
Self-citation

Sorted by citations

Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Self-citation
Emerging issues in probiotic safety: 2023 perspectives
Merenstein, D., Pot, B., Leyer, G., Ouwehand, A. C., Preidis, G. A., Elkins, C. A., Hill, C., Lewis, Z. T., Shane, A. L., Zmora, N., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185034 · Cited by 481
The Female Vaginal Microbiome in Health and Bacterial Vaginosis
Chen, X. F., Lu, Y., Chen, T., & Li, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.631972 · Cited by 508
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M. A., Brown, S. E., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 412
Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease
Ravel, J., Moreno, I., & Simón, C. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.019 · Cited by 375

See all 383

Authors: Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., & Hemmerling, A.
Affiliations: University of California, San Francisco (US)
Rush University Medical Center (US)
ORCID: Cohen, Craig R.
French, Audrey L.
Newmann, Sara
Reno, Hilary
Green, Lauri
Miller, Steve
Parks, Thomas
Hemmerling, Anke
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-05-14
Volume: 382
Issue: 20
Pages: 1906-1915
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1915254
PMC: PMC7362958
OpenAlex: W3024851520
Cited by: 377
References: 45
Citations by year: 2026: 71 · 2025: 70 · 2024: 55 · 2023: 60 · 2022: 47 · 2021: 52 · 2020: 22
FWCI: 33.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute of Allergy and Infectious Diseases (HHSN272201300014I/HHSN27200007)
Topics: Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Health Sciences › Medicine › Urology › Urinary Tract Infections Management
Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords: bacterial vaginosis, recurrence prevention, vaginal probiotics, Lactobacillus, metronidazole, vaginal treatment, adverse events
MeSH terms: Lactobacillus crispatus, Administration, Intravaginal, Adolescent, Adult, Antibiosis, Anti-Bacterial Agents, Double-Blind Method, Female, Gels, Humans, Metronidazole, Middle Aged, Vagina, Incidence, Vaginosis, Bacterial, Secondary Prevention, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks